Amrize (AMRZ) EBT (2024 - 2026)

Amrize (AMRZ) has 3 years of EBT data on file, last reported at -$145.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 9.02% year-over-year to -$145.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (down 4.26% YoY), and the FY2025 full-year result was $1.5 billion, down 8.05% from the prior year.
• EBT slipped to -$145.0 million in Q1 2026, from $392.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $703.0 million in Q3 2024 to a low of -$145.0 million in Q1 2026.
• A 3-year average of $379.5 million and a median of $470.5 million in 2025 frame the typical range for EBT.
• Peak annual rise in EBT reached 8.59% in 2025, while the deepest fall reached 11.45% in 2025.
• Tracing AMRZ's EBT over 3 years: stood at $361.0 million in 2024, then climbed by 8.59% to $392.0 million in 2025, then slumped by 136.99% to -$145.0 million in 2026.
• Business Quant data shows AMRZ's EBT at -$145.0 million in Q1 2026, $392.0 million in Q4 2025, and $689.0 million in Q3 2025.